Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Molecular design, development

Parallel to that the MDL Molfile format (see the Tutorial in Section 2.4.6) developed at Molecular Design Limited (now MDL Information Systems, Inc.) became a de facto standard file format [50]. [Pg.45]

I-J 1994. The Development of a Simple Empirical Scoring Fimction to Estimate the Binding istant for a Protein-ligand Complex of Known Three-Dimensional Structure. Journal of nputer-Aided Molecular Design 8 243-256. [Pg.736]

Eldridge M D, C W Murray, T R Auton, G V Paoliniand R P Mee 1997. Empirical Scoring Functions 1 The Development of a Fast Empirical Scoring Fimction to Estimate the Binding Affinity of Ligand in Receptor Complexes. Journal of Computer-Aided Molecular Design 11 425-445. [Pg.737]

Nuclear Magnetic Resonance Spectroscopy. Bmker s database, designed for use with its spectrophotometers, contains 20,000 C-nmr and H-nmr, as weU as a combined nmr-ms database (66). Sadder Laboratories markets a PC-based system that can search its coUection of 30,000 C-nmr spectra by substmcture as weU as by peak assignments and by fiiU spectmm (64). Other databases include one by Varian and a CD-ROM system containing polymer spectra produced by Tsukuba University, Japan. CSEARCH, a system developed at the University of Vieima by Robien, searches a database of almost 16,000 C-nmr. Molecular Design Limited (MDL) has adapted the Robien database to be searched in the MACCS and ISIS graphical display and search environment (63). Projects are under way to link the MDL system with the Sadder Hbrary and its unique search capabiHties. [Pg.121]

It has been demonstrated that a variety of different polyphosphazenes can be developed as biomaterials, membranes or hydrogels, bioactive polymers, and bioerodible polymers. As with most new areas of polymer chemistry and biomaterials science, molecular design forms the basis of most new advances, but the rate-controlling step is the testing and evaluation of the materials in both in vitro and in vivo environments. This is particularly true for polyphosphazenes where the availability of research quantities only has limited the... [Pg.188]

B. A., Laufer, J. Description of several chemical structure file formats used by computer programs developed at Molecular Design Limited. J. Chem. Inf. Comput. Sci. 1992, 32, 244-255. [Pg.181]

The polyphosphazenes are high molecular weight polymers with a wide range of novel and potentially useful properties. The large number of different pendant groups with widely varied functionality which can be attached to the P-N backbone demonstrate the unusual molecular design potential of this class of polymers. Undoubtedly, some of these will hold promise for future research and development. [Pg.276]

Whereas molecular design is a strategy applicable to the chemical level of epitope-paratope interactions, it cannot be used for optimizing the many cellular interactions required for achieving an immune response that leads to infectivity neutralization of a pathogen. As a result, the future development of vaccines will continue to rely more on the empirical testing of the protection afforded by candidate vaccine preparations than on the rational design of biomolecules defined in a reductionist manner by their chemical structure. [Pg.64]

P-N backbone demonstrate the unusual molecular design potential of this class of polymers. Undoubtedly, some of these will hold promise for future research and development. [Pg.240]

The molecular design of stereospecific homogeneous catalysts for polymerization and oligomerization has now reached a practical stage, which is the result of the rapid developments in early transition metal organometallic chemistry in this decade. In fact, Exxon and Dow are already producing polyethylene commercially with the help of metallocene catalysts. Compared to the polymerization of a-olefins, the polymerization of polar vinyl, alkynyl and cyclic monomers seems to be less developed. [Pg.45]

Scheme 11. Development of non-peptide Src SH2 domain antagonists emerging from a computer-aided molecular design strategy... [Pg.50]

Bremner, J.B., Coban, B. and Griffith, R. (1996) Pharmacophore development for antagonists at alpha 1 adrenergic receptor subtypes. Journal of Computer-Aided Molecular Design, 10, 545-557. [Pg.192]


See other pages where Molecular design, development is mentioned: [Pg.107]    [Pg.123]    [Pg.107]    [Pg.123]    [Pg.47]    [Pg.114]    [Pg.130]    [Pg.357]    [Pg.424]    [Pg.12]    [Pg.13]    [Pg.15]    [Pg.1]    [Pg.7]    [Pg.21]    [Pg.470]    [Pg.31]    [Pg.51]    [Pg.153]    [Pg.741]    [Pg.31]    [Pg.35]    [Pg.35]    [Pg.160]    [Pg.135]    [Pg.7]    [Pg.193]    [Pg.275]    [Pg.61]    [Pg.62]    [Pg.71]    [Pg.291]    [Pg.37]    [Pg.73]    [Pg.10]    [Pg.399]    [Pg.41]    [Pg.31]    [Pg.1361]    [Pg.693]   
See also in sourсe #XX -- [ Pg.326 ]




SEARCH



Accelerating Diagnostic Product Development Process with Molecular Rational Design and Directed Evolution

Molecular catalysts designing, with development

Molecular development

© 2024 chempedia.info